{
  "DOI": "10.1038/s41431-017-0017-y",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-017-0017-y",
  "alternative-id": [
    "17"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "4 May 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "13 September 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "14 September 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "27 October 2017"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Nunes",
      "given": "Bruno Ghirotto",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Loures",
      "given": "Flávio Vieira",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bueno",
      "given": "Heloisa Maria Siqueira",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cangussu",
      "given": "Erica Baroni",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goulart",
      "given": "Ernesto",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Coatti",
      "given": "Giuliana Castello",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Caldini",
      "given": "Elia Garcia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Condino-Neto",
      "given": "Antonio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zatz",
      "given": "Mayana",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        10,
        27
      ]
    ],
    "date-time": "2017-10-27T13:35:08Z",
    "timestamp": 1509111308000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:41:19Z",
    "timestamp": 1684618879000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        20
      ]
    ],
    "date-time": "2023-08-20T01:18:01Z",
    "timestamp": 1692494281547
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2017,
        10,
        27
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2017,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            10,
            27
          ]
        ],
        "date-time": "2017-10-27T00:00:00Z",
        "timestamp": 1509062400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-017-0017-y",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-017-0017-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-017-0017-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1388-1396",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2017,
        10,
        27
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        10,
        27
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1146/annurev-genom-090314-025003",
      "author": "S Guiraud",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "journal-title": "Annu Rev Genom Hum Genet",
      "key": "17_CR1",
      "unstructured": "Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. The pathogenesis and therapy of muscular dystrophies. Annu Rev Genom Hum Genet. 2015;16:281–308.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/sj.embor.7400221",
      "author": "KJ Nowak",
      "doi-asserted-by": "publisher",
      "first-page": "872",
      "journal-title": "EMBO Rep",
      "key": "17_CR2",
      "unstructured": "Nowak KJ, Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep. 2004;5:872–76.",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ncomms14454",
      "doi-asserted-by": "publisher",
      "key": "17_CR3",
      "unstructured": "Bengtsson NE, Hall JK, Odom GL, et al. Muscle specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat Commun. 2017;8. \n                    https://doi.org/10.1038/ncomms14454\n                    \n                  ."
    },
    {
      "DOI": "10.1093/hmg/10.15.1547",
      "author": "JC Deutekom Van",
      "doi-asserted-by": "publisher",
      "first-page": "1547",
      "journal-title": "Hum Mol Genet",
      "key": "17_CR4",
      "unstructured": "Van Deutekom JC, Bremmer-Bout M, Janson AA, et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet. 2001;10:1547–54.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1097/01.phm.0000184156.98671.d0",
      "author": "B Balaban",
      "doi-asserted-by": "publisher",
      "first-page": "843",
      "journal-title": "Am J Phys Med Rehabil",
      "key": "17_CR5",
      "unstructured": "Balaban B, Matthews DJ, Clayton GH, Carry T. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil. 2005;84:843–50.",
      "volume": "84",
      "year": "2005"
    },
    {
      "author": "AS Rosenberg",
      "journal-title": "Sci Transl Med",
      "key": "17_CR6",
      "unstructured": "Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, Wakefield LM, Woodcock J. Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med. 2015;7:299.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1006/clim.2000.4966",
      "author": "MJ Spencer",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "journal-title": "Clin Immunol",
      "key": "17_CR7",
      "unstructured": "Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG. Helper (CD4+) and Cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol. 2001;98:235–43.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1111/cei.12555",
      "author": "S Jolles",
      "doi-asserted-by": "publisher",
      "first-page": "163",
      "journal-title": "Clin Exp Immunol",
      "key": "17_CR8",
      "unstructured": "Jolles S, Jordan SC, Orange JS, van Schaik IN. Immunoglobulins: current understanding and future directions. Clin Exp Immunol. 2014;178:163–8.",
      "volume": "178",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nri3401",
      "author": "I Schwab",
      "doi-asserted-by": "publisher",
      "first-page": "176",
      "journal-title": "Nat Rev Immunol",
      "key": "17_CR9",
      "unstructured": "Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13:176–89.",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1084/jem.20061788",
      "author": "F Nimmerjahn",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "J Exp Med",
      "key": "17_CR10",
      "unstructured": "Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204:11–5.",
      "volume": "204",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.291.19.2367",
      "author": "MC Dalakas",
      "doi-asserted-by": "publisher",
      "first-page": "2367",
      "journal-title": "JAMA",
      "key": "17_CR11",
      "unstructured": "Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004;291:2367–75.",
      "volume": "291",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.jaci.2010.10.030",
      "author": "M Ballow",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "journal-title": "J Allerg Clin Immunol",
      "key": "17_CR12",
      "unstructured": "Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allerg Clin Immunol. 2011;127:315–23.",
      "volume": "127",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrneurol.2014.253",
      "author": "JD Lünemann",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "Nat Rev Neurol",
      "key": "17_CR13",
      "unstructured": "Lünemann JD, Nimmerjahn F, Dalakas MC. Intravenous immunoglobulin in neurology-mode of action and clinical efficacy. Nat Rev Neurol. 2015;11:80–9.",
      "volume": "11",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrrheum.2011.61",
      "author": "J Bayry",
      "doi-asserted-by": "publisher",
      "first-page": "349",
      "journal-title": "Nat Rev Rheumatol",
      "key": "17_CR14",
      "unstructured": "Bayry J, Negi VS, Kaveri SV. Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7:349–59.",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1084/jem.176.6.1693",
      "author": "K Inaba",
      "doi-asserted-by": "publisher",
      "first-page": "1693",
      "journal-title": "J Exp Med",
      "key": "17_CR15",
      "unstructured": "Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693–702.",
      "volume": "176",
      "year": "1992"
    },
    {
      "DOI": "10.1111/jnc.13269",
      "author": "J Zschüntzsch",
      "doi-asserted-by": "publisher",
      "first-page": "351",
      "journal-title": "J Neurochem",
      "key": "17_CR16",
      "unstructured": "Zschüntzsch J, Zhang Y, Klinker F, et al. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy. J Neurochem. 2016;136:351–62.",
      "volume": "136",
      "year": "2016"
    },
    {
      "DOI": "10.1242/dmm.018424",
      "author": "JW McGreevy",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Dis Model Mech",
      "key": "17_CR17",
      "unstructured": "McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech. 2015;8:195–213.",
      "volume": "8",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S0092-8674(00)80532-2",
      "author": "AE Deconinck",
      "doi-asserted-by": "publisher",
      "first-page": "717",
      "journal-title": "Cell",
      "key": "17_CR18",
      "unstructured": "Deconinck AE, Rafael JA, Skinner JA, et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 1997;90:717–27.",
      "volume": "90",
      "year": "1997"
    },
    {
      "DOI": "10.1038/mt.2016.162",
      "author": "A Farini",
      "doi-asserted-by": "publisher",
      "first-page": "1898",
      "journal-title": "Mol Ther",
      "key": "17_CR19",
      "unstructured": "Farini A, Sitzia C, Cassani B, et al. Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy. Mol Ther. 2016;24:1898–1912.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.nmd.2015.02.007",
      "author": "M Zatz",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "journal-title": "Neuromuscul Disord",
      "key": "17_CR20",
      "unstructured": "Zatz M, Vieira NM, Zucconi E, et al. A normal life without muscle dystrophin. Neuromuscul Disord. 2015;25:371–4.",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.nmd.2015.02.012",
      "author": "NM Vieira",
      "doi-asserted-by": "publisher",
      "first-page": "363",
      "journal-title": "Neuromuscul Disord",
      "key": "17_CR21",
      "unstructured": "Vieira NM, Guo LT, Estrela E, Kunkel LM, Zatz M, Shelton GD. Muscular dystrophy in a family of labrador retrievers with no muscle dystrophin and a mild phenotype. Neuromuscul Disord. 2015;25:363–70.",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2015.10.049",
      "author": "NM Vieira",
      "doi-asserted-by": "publisher",
      "first-page": "1204",
      "journal-title": "Cell",
      "key": "17_CR22",
      "unstructured": "Vieira NM, Elvers I, Alexander MS, et al. Jagged 1 rescues the duchenne muscular dystrophy phenotype. Cell. 2015;163:1204–13.",
      "volume": "163",
      "year": "2015"
    },
    {
      "DOI": "10.1080/21675511.2015.1010966",
      "doi-asserted-by": "publisher",
      "key": "17_CR23",
      "unstructured": "Villalta SA, Rosenberg AS, Bluestone JA. The immune system in Duchenne muscular dystrophy: friend or foe. Rare Dis. 2015;3. \n                    https://doi.org/10.1080/21675511.2015.1010966\n                    \n                  ."
    },
    {
      "DOI": "10.1182/blood-2002-05-1447",
      "author": "J Bayry",
      "doi-asserted-by": "publisher",
      "first-page": "758",
      "journal-title": "Blood",
      "key": "17_CR24",
      "unstructured": "Bayry J, Lacroix-Desmazes S, Carbonneil C, et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 2003;101:758–65.",
      "volume": "101",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJMoa1000228",
      "author": "JR Mendell",
      "doi-asserted-by": "publisher",
      "first-page": "1429",
      "journal-title": "N Engl J Med",
      "key": "17_CR25",
      "unstructured": "Mendell JR, Campbell K, Rodino-Klapac L, et al. Dystrophin immunity in Duchenne’s muscular dystrophy. N Engl J Med. 2010;362:1429–37.",
      "volume": "362",
      "year": "2010"
    },
    {
      "DOI": "10.1038/mt.2016.163",
      "author": "C Sitzia",
      "doi-asserted-by": "publisher",
      "first-page": "1949",
      "journal-title": "Mol Ther",
      "key": "17_CR26",
      "unstructured": "Sitzia C, Farini A, Jardim L, et al. Adaptive immune response impairs the efficacy of autologous transplantation of engineered stem cells in dystrophic dogs. Mol Ther. 2016;24:1949–64.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1038/sj.gt.3301259",
      "author": "A Ferrer",
      "doi-asserted-by": "publisher",
      "first-page": "1439",
      "journal-title": "Gene Ther",
      "key": "17_CR27",
      "unstructured": "Ferrer A, Wells KE, Wells DJ. Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther. 2000;7:1439–46.",
      "volume": "7",
      "year": "2000"
    },
    {
      "DOI": "10.1038/nri.2016.150",
      "author": "JG Tidball",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "journal-title": "Nat Rev Immunol",
      "key": "17_CR28",
      "unstructured": "Tidball JG. Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol. 2017;17:165–78.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1152/ajpregu.00735.2009",
      "author": "JG Tidball",
      "doi-asserted-by": "publisher",
      "first-page": "1173",
      "journal-title": "Am J Physiol Regul Integr Comp Physiol",
      "key": "17_CR29",
      "unstructured": "Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 2010;298:1173–87.",
      "volume": "298",
      "year": "2010"
    },
    {
      "DOI": "10.1128/MCB.05397-11",
      "author": "P Londhe",
      "doi-asserted-by": "publisher",
      "first-page": "2854",
      "journal-title": "Mol Cell Biol",
      "key": "17_CR30",
      "unstructured": "Londhe P, Davie JK. γ-Interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA. Mol Cell Biol. 2011;31:2854–66.",
      "volume": "31",
      "year": "2011"
    },
    {
      "DOI": "10.1126/scisignal.2004633",
      "author": "P Londhe",
      "doi-asserted-by": "publisher",
      "journal-title": "Sci Signal",
      "key": "17_CR31",
      "unstructured": "Londhe P, Davie JK. Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis. Sci Signal. 2013;6:ra107.",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0012479",
      "author": "S Acharyya",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "17_CR32",
      "unstructured": "Acharyya S, Sharma SM, Cheng AS, et al. TNF inhibits NOTCH1 in skeletal muscle cells by EZH2 and DNA methylation mediated repression: implications in Duchenne muscular dystrophy. PLoS One. 2010;5:e12479. \n                    https://doi.org/10.1371/journal.pone.0012479",
      "volume": "5",
      "year": "2010"
    },
    {
      "author": "C Duhem",
      "first-page": "79",
      "journal-title": "Clin Exp Immunol",
      "key": "17_CR33",
      "unstructured": "Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol. 1994;97:79–83.",
      "volume": "97",
      "year": "1994"
    },
    {
      "DOI": "10.1016/S0140-6736(02)07275-6",
      "author": "B Godeuau",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Lancet",
      "key": "17_CR34",
      "unstructured": "Godeuau B, Chevret S, Varet B, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002;359:23–9.",
      "volume": "359",
      "year": "2002"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-017-0017-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin–utrophin double knockout mice"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "25"
}